Are COVID-19 mRNA shots safe for patients with Inflammatory Bowel Disease, like Crohn’s?
Certain establishment medical societies “strongly recommend” COVID-19 vaccination for such patients.
On the other hand, physicians in the field need to keep a close eye on IBD patients who receive a shot.
One physician reports this case:
Abbvie, the manufacturer of Humira states:
At this time, the safety and efficacy of the authorized COVID-19 vaccines have not been established in immunocompromised persons, persons with autoimmune conditions or persons who take immunosuppressive medications or therapies1 such as HUMIRA. Each patient’s unique clinical circumstances should be considered when managing their HUMIRA therapy and when deciding if a vaccine is appropriate for them.https://www.humirapro.com/covid19
Not to mention that studies are showing that “COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant[s]” like Humira:
Other physicians are reporting adverse reactions in this population as well.
In The American Journal of Gastroenterology (October 2021) doctors report an “Acute Exacerbation of Crohn’s Disease After COVID-19 Pfizer Vaccine” in a 33 year old male.
And doctors in Japan report on “Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2” in a 64-year-old woman.
The bottom line is that the jury is still out on many important questions like this during the ongoing pandemic. Physicians must retain the ability to use their professional judgement to treat patients as individuals and not be coerced into the one-size-fits-all protocols pushed by bureaucrats who are not actually responsible for patient care.